Anavex appoints Robert Chisholm CFO
This article was originally published in Scrip
Anavex Life Sciences, a Vancouver-based pharmaceutical company developing novel drug candidates, has appointed Robert Chisholm CFO. Mr Chisholm has served on the Anavex board since May 2011 and will remain a director in addition to his new role. Mr Chisholm has been CFO of both Savary Capital and OMT since March 2011 and July 2011 respectively, and is currently CFO of TMT Resources, Emprise Capital Corp and Ripper Oil and Gas. He also serves on the board of Rare Earth Industries. Additionally, Harvey Lalach has resigned as a director and officer of the company. Mr Chisholm will serve as interim president.